Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P I Clark

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
International Journal of Colorectal Disease|February 1, 1987
Two randomised phase II trials of intermittent intravenous versus subcutaneous alpha-2 interferon alone (trial 1) and in combination with 5-fluorouracil (trial 2) in advanced colorectal cancerP I Clark, M L Slevin, R H Reznek, et al.
Chemical Research in Toxicology|September 6, 2011
Effect of cigarette menthol content on mainstream smoke emissionsS M Gordon, M C Brinkman, R Q Meng, et al.
Lancet (London, England)|October 14, 1989
Intensive treatment of multiple myeloma and criteria for complete remissionM E Gore, P J Selby, C Viner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancerM L Slevin, P I Clark, S P Joel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1994
A randomized trial of two etoposide schedules in small-cell lung cancer: the influence of pharmacokinetics on efficacy and toxicityP I Clark, M L Slevin, S P Joel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1995
Myeloma during a decade: clinical experience in a single centreJ S Malpas, R K Ganjoo, P W Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999
Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancerJ von Pawel, J H Schiller, F A Shepherd, et al.
British Journal of Cancer|July 29, 1999
Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumoursS D Fosså, S P Stenning, A Gerl, et al.
British Journal of Cancer|December 4, 1998
Chemotherapy for ovarian cancer--a consensus statement on standard practiceM Adams, A H Calvert, J Carmichael, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
International Journal of Colorectal Disease|February 1, 1987
Two randomised phase II trials of intermittent intravenous versus subcutaneous alpha-2 interferon alone (trial 1) and in combination with 5-fluorouracil (trial 2) in advanced colorectal cancerP I Clark, M L Slevin, R H Reznek, et al.
Chemical Research in Toxicology|September 6, 2011
Effect of cigarette menthol content on mainstream smoke emissionsS M Gordon, M C Brinkman, R Q Meng, et al.
Lancet (London, England)|October 14, 1989
Intensive treatment of multiple myeloma and criteria for complete remissionM E Gore, P J Selby, C Viner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancerM L Slevin, P I Clark, S P Joel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1994
A randomized trial of two etoposide schedules in small-cell lung cancer: the influence of pharmacokinetics on efficacy and toxicityP I Clark, M L Slevin, S P Joel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1995
Myeloma during a decade: clinical experience in a single centreJ S Malpas, R K Ganjoo, P W Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999
Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancerJ von Pawel, J H Schiller, F A Shepherd, et al.
British Journal of Cancer|July 29, 1999
Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumoursS D Fosså, S P Stenning, A Gerl, et al.
British Journal of Cancer|December 4, 1998
Chemotherapy for ovarian cancer--a consensus statement on standard practiceM Adams, A H Calvert, J Carmichael, et al.
Pageof 7